It is widely recognized that oncogene c-Myc has a vital role in the pathophysiology of MM and is regulated by a large network of interconnected signaling pathways involves MAPK, PI3K/Akt, JAK/STAT, and NF-κB26–29. This evidence concerns the gene AKT1 and Miyoshi myopathy.